Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under Preemptive Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00167557
Recruitment Status : Withdrawn (The PI left the institution.)
First Posted : September 14, 2005
Last Update Posted : November 19, 2013
Astellas Pharma US, Inc.
Information provided by (Responsible Party):
The University of Texas Health Science Center, Houston

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : March 2008
  Study Completion Date : March 2008